Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Intelligent Monitoring to Predict Atrial Fibrillation

View source ↗

Summary

The clinical trial investigating intelligent monitoring to predict atrial fibrillation has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Liverpool University Hospitals NHS Foundation Trust | Conditions: Atrial Fibrillation New Onset, Postoperative Cardiovascular Complications | Status: SUSPENDED